pazoren-200 tablet
renata limited, gazipur - pazopanib - tablet - 200 mg
votrient film-coated tablet
glaxo - pazopanib hydrochloride - film-coated tablet - 200 mg
votrient film-coated tablet
glaxo - pazopanib hydrochloride - film-coated tablet - 400 mg
zotrix 400 tablet
jenphar bangladesh ltd. - pazopanib - tablet - 400 mg
zopatin tablet
techno drugs ltd. - pazopanib - tablet - 200 mg
votrient tablets film-coated
lek pharmaceuticals d.d. - pazopanib - tablets film-coated - 400mg
zotrix 200 tablet
jenphar bangladesh ltd. - pazopanib - tablet - 200 mg
votrient tablets 200mg (ヴォトリエント錠200mg)
novartis pharma k.k. - pazopanib hydrochloride - light red tablet, major axis: 14.3 mm, minor axis: 5.6 mm, thickness: 5.3 mm
lojuxta 10 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 10 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).
lojuxta 20 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 20 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).